Hepatocyte growth factor suppresses tumor cell apoptosis in nasopharyngeal carcinoma by upregulating Bcl-2 protein expression

Pathology Research and Practice

Volumn 205, Issue 12, 2009, Pages 828-837

  Li juan, Bian ^a   Bing, Liao ^a   Zhi, Li ^a   Yang, Li ^a   Ying jie, Liang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Antiapoptotic Bcl 2 protein; Apoptosis; Hepatocyte growth factor (HGF); Nasopharyngeal carcinoma (NPC)

Indexed keywords

BAX PROTEIN, HUMAN; HGF PROTEIN, HUMAN; PROTEIN BAX; PROTEIN BCL 2; SCATTER FACTOR;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; EPSTEIN BARR VIRUS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; MALE; METABOLISM; MIDDLE AGED; NASOPHARYNX TUMOR; NICK END LABELING; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TIME; TUMOR CELL LINE; UPREGULATION; VIROLOGY; WESTERN BLOTTING;

ADULT; AGED; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; HEPATOCYTE GROWTH FACTOR; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TIME FACTORS; UP-REGULATION; YOUNG ADULT;

EID: 75549088822     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2009.06.016     Document Type: Article

References (40)

1. Bardelli A., Longati P., Albero D., Goruppi S., Schneider C., Ponzetto C., Comoglio P.M. HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death. EMBO J. 1996, 15:6205-6212.
2. Compagni A., Christofori G. Recent advances in research on multistage tumorigenesis. Br. J. Cancer 2000, 83:1-5.
3. Fanidi A., Harrington E.A., Evan G.I. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 1992, 359:554-556.
4. Jayasurya A., Dheen S.T., Yap W.M., Tan N.G., Ng Y.K., Bay B.H. Inducible nitric oxide synthase and bcl-2 expression in nasopharyngeal cancer: correlation with outcome of patients after radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2003, 56:837-845.
5. Ma B.B., Chan A.T. Systemic treatment strategies and therapeutic monitoring for advanced nasopharyngeal carcinoma. Expert Rev. Anticancer Ther. 2006, 6:383-394.
6. Feng B.J., Jalbout M., Ayoub W.B., Khyatti M., Dahmoul S., Ayad M., Maachi F., Bedadra W., Abdoun M., Mesli S., Hamdi-Cherif M., Boualga K., Bouaouina N., Chouchane L., Benider A., Ben Ayed F., Goldgar D., Corbex M. Dietary risk factors for nasopharyngeal carcinoma in Maghrebian countries. Int. J. Cancer 2007, 121:1550-1555.
7. Feng B.J., Huang W., Shugart Y.Y., Lee M.K., Zhang F., Xia J.C., Wang H.Y., Huang T.B., Jian S.W., Huang P., Feng Q.S., Huang L.X., Yu X.J., Li D., Chen L.Z., Jia W.H., Fang Y., Huang H.M., Zhu J.L., Liu X.M., Zhao Y., Liu W.Q., Deng M.Q., Hu W.H., Wu S.X., Mo H.Y., Hong M.F., King M.C., Chen Z., Zeng Y.X. Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat. Genet. 2002, 31:395-399.
8. Qian C.N., Guo X., Cao B., Kort E.J., Lee C.C., Chen J., Wang L.M., Mai W.Y., Min H.Q., Hong M.H., Vande Woude G.F., Resau J.H., The B.T. Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma. Cancer Res. 2002, 62:589-596.
9. Green D.R., Reed J.C. Mitochondria and apoptosis. Science 1998, 281:1309-1312.
10. Kankuri E., Cholujova D., Comajova M., Vaheri A., Bizik J. Induction of hepatocyte growth factor/scatter factor by fibroblast clustering directly promotes tumor cell invasiveness. Cancer Res. 2005, 65:9914-9922.
11. Harada H., Grant S. Apoptosis regulators. Rev. Clin. Exp. Hematol. 2003, 7:117-138.
12. Min H., Hong M., Ma J., Zhang E., Zheng Q., Zhang J., Zhang J., Zhang F., Su Y., Qiu F. A new staging system for nasopharyngeal carcinoma in China. Int. J. Radiat. Oncol. Biol. Phys. 1994, 30:1037-1042.
13. Wang H.G., Takayama S., Rapp U.R., Reed J.C. Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1. Proc. Natl. Acad. Sci. USA 1996, 93:7063-7068.
14. Harn H.J., Hsieh H.F., Ho L.I., Yu C.P., Chen J.H., Chiu C.C., Fan H.C., Lee W.H. Apoptosis in nasopharyngeal carcinoma as related to histopathological characteristics and clinical stage. Histopathology 1998, 33:117-122.
15. Lacy J., Loomis R., Grill S., Srimatkandada P., Carbone R., Cheng Y.C. Systemic Bcl-2 antisense oligodeoxynucleotide in combination with cisplatin cures EBV+ nasopharyngeal carcinoma xenografts in SCID mice. Int. J. Cancer 2006, 119:309-316.
16. Spano J.P., Busson P., Atlan D., Bourhis J., Pignon J.P., Esteban C., Armand J.P. Nasopharyngeal carcinomas: an update. Eur. J. Cancer 2003, 39:2121-2135.
17. Lin J.C., Jan J.S., Hsu C.Y., Jiang R.S., Wang W.Y. Outpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma: high complete response and low toxicity rates. Br. J. Cancer 2003, 88:187-194.
18. Kitta K., Day R.M., Kim Y., Torregroza I., Evans T., Suzuki Y.J. Hepatocyte growth factor induces GATA-4 phosphorylation and cell survival in cardiac muscle cells. J. Biol. Chem. 2003, 278:4705-4712.
19. Yamamoto K., Morishita R., Hayashi S., Matsushita H., Nakagami H., Moriguchi A., Matsumoto K., Nakamura T., Kaneda Y., Ogihara T. Contribution of Bcl-2, but not Bcl-xL and Bax, to antiapoptotic actions of hepatocyte growth factor in hypoxia-conditioned human endothelial cells. Hypertension 2001, 37:1341-1348.
20. Kinzler K.W., Vogelstein B. Landscaping the cancer terrain. Science 1998, 280:1036-1037.
21. Yip K.W., Shi W., Pintilie M., Martin J.D., Mocanu J.D., Wong D., MacMillan C., Gullane P., O'Sullivan B., Bastianutto C., Liu F.F. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer. Clin. Cancer Res. 2006, 12:5726-5732.
22. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
23. Gao M., Fan S., Goldberg I.D., Laterra J., Kitsis R.N., Rosen E.M. Hepatocyte growth factor/scatter factor blocks the mitochondrial pathway of apoptosis signaling in breast cancer cells. J. Biol. Chem. 2001, 276:47257-47265.
24. Nishino M., Iimuro Y., Ueki T., Hirano T., Fujimoto J. Hepatocyte growth factor improves survival after partial hepatectomy in cirrhotic rats suppressing apoptosis of hepatocytes. Surgery 2008, 144:374-384.
25. Boros P., Miller C.M. Hepatocyte growth factor: a multifunctional cytokine. Lancet 1995, 345:293-295.
26. Hulley P.A., Gordon F., Hough F.S. Inhibition of mitogen-activated protein kinase activity and proliferation of an early osteoblast cell line (MBA15.4) by dexamethasone: role of protein phosphatases. Endocrinology 1998, 139:2423-2431.
27. Lu Q.L., Elia G., Lucas S., Thomas J.A. Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma. Int. J. Cancer 1993, 53:29-35.
28. Foote R.L., Weidner N., Harris J., Hammond E., Lewis J.E., Vuong T., Ang K.K., Fu K.K. Evaluation of tumor angiogenesis measured with microvessel density (MVD) as a prognostic indicator in nasopharyngeal carcinoma: results of RTOG 9505. Int. J. Radiat. Oncol. Biol. Phys. 2005, 61:745-753.
29. Ding S., Merkulova-Rainon T., Han Z.C., Tobelem G. HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro. Blood 2003, 101:4816-4822.
30. Fan S., Wang J.A., Yuan R.Q., Rockwell S., Andres J., Zlatapolskiy A., Goldberg I.D., Rosen E.M. Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents. Oncogene 1998, 17:131-141.
31. Henderson S., Rowe M., Gregory C., Croom-Carter D., Wang F., Longnecker R., Kieff E., Rickinson A. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991, 65:1107-1115.
32. Fan S.Q., Ma J., Zhou J., Xiong W., Xiao B.Y., Zhang W.L., Tan C., Li X.L., Shen S.R., Zhou M., Zhang Q.H., Ou Y.J., Zhuo H.D., Fan S., Zhou Y.H., Li G.Y. Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis. Hum. Pathol. 2006, 37:593-605.
33. Sato T., Hanada M., Bodrugh S., Irie S., Iwama N., Boise L., Thompson C., Golemis E., Fong L., Wang H.G., et al. Interactions among members of the bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. USA 1994, 91:9238-9242.
34. Sheng W., Decaussin G., Sumner S., Ooka T. N-terminal domain of BARF1 gene encoded by Epstein-Barr virus is essential for malignant transformation of rodent fibroblasts and activation of BCL-2. Oncogene 2001, 20:1176-1185.
35. Zhang X., Wang Q., Ling M.T., Wong Y.C., Leung S.C., Wang X. Anti-apoptotic role of TWIST and its association with Akt pathway in mediating taxol resistance in nasopharyngeal carcinoma cells. Int. J. Cancer 2007, 120:1891-1898.
36. Guo Y., He J., Wu J., Yang L., Dai S., Tan X., Liang L. Locally overexpressing hepatocyte growth factor prevents post-ischemic heart failure by inhibition of apoptosis via calcineurin-mediated pathway and angiogenesis. Arch. Med. Res. 2008, 39:179-188.
37. Hirose Y., Masaki Y., Sasaki K., Ogawa Y., Takeshita S., Fukutoku M., Sugai S., Takiguchi T. Determination of Epstein-Barr virus association with B-cell lymphomas in Japan: study of 72 cases - in situ hybridization, polymerase chain reaction, immunohistochemical studies. Int. J. Hematol. 1998, 67:165-174.
38. Wang Y., Ahmad N., Wani M.A., Ashraf M. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis. J. Mol. Cell Cardiol. 2004, 37:1041-1052.
39. Li Z., Lin S.X., Liang H.Z., He J.H. Expression of hepatocyte growth factor/c-Met system in nasopharyngeal carcinoma and its biological significance. Zhonghua Bing Li Xue Za Zhi 2005, 34:75-79.
40. Hu Z.Y., Zhu X.F., Zhong Z.D., Sun J., Wang J., Yang D., Zeng Y.X. ApoG2, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces apoptosis and suppresses tumor growth in nasopharyngeal carcinoma xenografts. Int. J. Cancer 2008, 123:2418-2429.